AHI — Advanced Health Intelligence Share Price
0.000.00%
Last trade - 00:00TechnologyHighly SpeculativeMicro Cap
- AU$20.03m
- AU$19.73m
- AU$2.79m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 9.88 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 7.18 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -376.24% | ||
| Return on Equity | -242.4% | ||
| Operating Margin | -388.32% | ||
Financial Summary
| Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 0.9 | 0.67 | 1.24 | 0.6 | 2.79 | n/a | n/a | 6.04% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Advanced Health Intelligence Limited is an Australia-based company that provides biometric-derived digital healthcare solutions. The Company’s products include Biometric Health Assessment (BHA), FaceScan, and BodyScan. Its BHA delivers preventative healthcare measures and refines risk stratification across populations. Its comprehensive insights cover a range of health vitals and risk predictions, allowing its partners to guide individuals into personalized stepped-care pathways. This includes connecting high-risk individuals to traditional primary care, telehealth, or e-health programs. FaceScan estimates vital signs and predicts the risk of chronic disease on a smartphone or Web browser. FaceScan provides estimated readings on heart rate, respiration rate, blood pressure and more in 30 seconds or less. BodyScan is optimized to run on-device using only a smartphone, to deliver accurate body dimension and composition estimates in 60 seconds or less.
Directors
- Vlado Bosanac CHM
- Steven Richards CFO
- Anita Swan DMK
- William Bradford OTH
- Amar El-Sallam OTH
- Dato Low Koon Poh NED
- Michael Melby NED
- Nick Prosser NED
- Edward Greissing NID (70)
- Last Annual
- June 30th, 2023
- Last Interim
- June 30th, 2023
- Incorporated
- October 1st, 2014
- Public Since
- August 17th, 2015
- No. of Shareholders
- 4,289
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 217,703,969
- Address
- Unit 5, 71-73 South Perth Esplanade, PERTH, 6151
- Web
- https://www.ahi.tech/
- Phone
- +61 893169100
- Auditors
- PKF Brisbane Audit
Upcoming Events for AHI
Full Year 2024 Advanced Health Intelligence Ltd Earnings Release
Similar to AHI
3P Learning
Australian Stock Exchange - SEATS
5G Networks
Australian Stock Exchange - SEATS
8Common
Australian Stock Exchange - SEATS
ActivePort
Australian Stock Exchange - SEATS
AD1 Holdings
Australian Stock Exchange - SEATS
FAQ
What is the Advanced Health Intelligence share price?
As of Today at 19:00 UTC, shares in Advanced Health Intelligence are trading at AU$0.09. This share price information is delayed by 15 minutes.
How has the Advanced Health Intelligence share price performed this year?
Shares in Advanced Health Intelligence last closed at AU$0.09 and the price had moved by -5.15% over the past 365 days. In terms of relative price strength the Advanced Health Intelligence share price has underperformed the ASX All Ordinaries Index by -11.66% over the past year.
What are the analyst and broker recommendations for Advanced Health Intelligence?
There is no consensus recommendation for this security.
What is the Advanced Health Intelligence dividend yield?
Advanced Health Intelligence does not currently pay a dividend.
Does Advanced Health Intelligence pay a dividend?
Advanced Health Intelligence does not currently pay a dividend.
When does Advanced Health Intelligence next pay dividends?
Advanced Health Intelligence does not currently pay a dividend.
How do I buy Advanced Health Intelligence shares?
To buy shares in Advanced Health Intelligence you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Advanced Health Intelligence?
As of the previous close price of AU$0.09, shares in Advanced Health Intelligence had a market capitalisation of AU$20.03m.
Where are Advanced Health Intelligence shares listed?
Here are the trading details for Advanced Health Intelligence:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: AHI
What kind of share is Advanced Health Intelligence?
Based on an overall assessment of its quality, value and momentum Advanced Health Intelligence is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Advanced Health Intelligence share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Advanced Health Intelligence share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Advanced Health Intelligence. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -65.75%.
As of the last closing price of AU$0.09, shares in Advanced Health Intelligence were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Advanced Health Intelligence PE Ratio?
The Advanced Health Intelligence PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.09.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Advanced Health Intelligence?
Advanced Health Intelligence's management team is headed by:
- Vlado Bosanac - CHM
- Steven Richards - CFO
- Anita Swan - DMK
- William Bradford - OTH
- Amar El-Sallam - OTH
- Dato Low Koon Poh - NED
- Michael Melby - NED
- Nick Prosser - NED
- Edward Greissing - NID